- Home
- ASPS vs AKTX Comparison
ASPS vs AKTX Comparison
Compare ASPS & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- AKTX
- Stock Information
- Founded
- ASPS 1999
- AKTX N/A
- Country
- ASPS Luxembourg
- AKTX United States
- Employees
- ASPS N/A
- AKTX N/A
- Industry
- ASPS Other Consumer Services
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- AKTX Health Care
- Exchange
- ASPS Nasdaq
- AKTX Nasdaq
- Market Cap
- ASPS 24.1M
- AKTX 24.5M
- IPO Year
- ASPS N/A
- AKTX N/A
- Fundamental
- Price
- ASPS $0.67
- AKTX $1.13
- Analyst Decision
- ASPS
- AKTX
- Analyst Count
- ASPS 0
- AKTX 0
- Target Price
- ASPS N/A
- AKTX N/A
- AVG Volume (30 Days)
- ASPS 120.5K
- AKTX 29.8K
- Earning Date
- ASPS 03-13-2025
- AKTX 05-15-2025
- Dividend Yield
- ASPS N/A
- AKTX N/A
- EPS Growth
- ASPS N/A
- AKTX N/A
- EPS
- ASPS N/A
- AKTX N/A
- Revenue
- ASPS $150,354,000.00
- AKTX N/A
- Revenue This Year
- ASPS $47.29
- AKTX N/A
- Revenue Next Year
- ASPS N/A
- AKTX N/A
- P/E Ratio
- ASPS N/A
- AKTX N/A
- Revenue Growth
- ASPS 3.65
- AKTX N/A
- 52 Week Low
- ASPS $0.43
- AKTX $0.85
- 52 Week High
- ASPS $2.11
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- ASPS 42.52
- AKTX 55.37
- Support Level
- ASPS $0.65
- AKTX $1.24
- Resistance Level
- ASPS $0.78
- AKTX $1.56
- Average True Range (ATR)
- ASPS 0.08
- AKTX 0.12
- MACD
- ASPS -0.01
- AKTX 0.01
- Stochastic Oscillator
- ASPS 4.11
- AKTX 45.26
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).